CX3CL1 and brain inflammatory disease: Previous studies reported that cerebrospinal fluid levels of soluble fractalkine are elevated in patients with traumatic brain injury and inflammatory brain diseases (Kastenbauer et al., 2003; Rancan et al., 2004).